A Study to Evaluate the Use of a Smartphone App for Stroke Patients with Obstructive Sleep Apnea

Overview

About this study

The purpose of this study is to evaluate the use of a smartphone app for stroke patients with obstructive sleep apnea in order to better use their positive airway pressure (PAP) therapy.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Clinical diagnostic testing via laboratory or home-based sleep study indicates diagnosis of obstructive sleep apnea.
  • Currently use an appropriate Apple (iOS9 or higher) or Android (4.2 or higher) smartphone device.
  • Able to read and understand English.
  • Prescribed continuous or auto-titrated PAP treatment for obstructive sleep apnea.
  • Stroke diagnosis with stroke event occurring within 12 months of referral to Center for Sleep Medicine.
  • Functional and cognitive ability to manage smartphone application and PAP device with minimal to no assistance.
  • Agree to using a smartphone application and wearable wrist sensor.

Exclusion Criteria: 

  • Communication or cognitive impairments that limit ability to read and/or follow directions.
  • Currently participating in other lifestyle programs (e.g., active, formal weight loss program or research study; smoking cessation program, etc.).
  • Has lost 10lb or 4.5kg or more over the past 4 weeks.
  • Other acute or severe health, cognitive, or psychological conditions that prevent participation.
  • Pregnant, lactating, or trying to become pregnant.
  • Decide to use different PAP device than ResMED Airsense 10.
  • Prescribed high-dose benzodiazepines (equivalent to >1 mg lorazapam/night).
  • Daily opioid medication use at night.
  • Unwilling to discontinue use of any current wearable sensor for the duration of the trial.
  • Previous documented history of treatment/referral for claustrophobia.
  • Previous PAP use.
  • Other conditions determined by a sleep medicine team member that may interfere with full participation in the trial.
  • Planning to travel for more than seven consecutive nights during the trial.
  • Currently engaging in shiftwork defined as night shift or rotating day and night shifts.
  • Unwilling to have an in-person follow-up appointment at the Center for Sleep Medicine in Rochester.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Lori Rhudy, Ph.D., R.N.

Contact us for the latest status

Contact information:

Paul Timm

(507)266-6627

Timm.Paul@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available